---
$id: https://graph.org.ai/products/commodity/51192012
$type: Product
source: UNSPSC
code: "51192012"
title: "Nicoxamat"
class: "51192000"
classTitle: "Antigout drugs"
family: "51190000"
familyTitle: "Agents affecting water and electrolytes"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nicoxamat

**UNSPSC Code**: 51192012
**Class**: [Antigout drugs](Antigout drugs.mdx)
**Family**: [Agents affecting water and electrolytes](../Agents affecting water and electrolytes.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a uricosuric agent with the molecular formula C6H6N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z3H2D4MF7A, chemically known as 3-pyridinecarboxamide, n-hydroxy- but generally known as nicoxamat, which bears US NIH Compound Identifier 71211. European Medicines Agency schedules Nicoxamat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09249MIG. The term NICOXAMAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). NICOXAMAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nicoxamat under HS 29333999 and SITC 51574. As of Q4 2014, NICOXAMAT remains the US FDA Preferred Term for this commodity. Nicoxamat bears US NLM identifiers UMLS ID C2698465 and NCI Concept Code C77068. SMILES: O=C(NO)C1CCCNC1.

